Prolymphangiogenic Effects of 9-cis Retinoic Acid Are Enhanced at Sites of Lymphatic Injury and Dependent on Treatment Duration in Experimental Postsurgical Lymphedema.
Prolymphangiogenic Effects of 9-cis Retinoic Acid Are Enhanced at Sites of Lymphatic Injury and Dependent on Treatment Duration in Experimental Postsurgical Lymphedema.
复制标题
9-顺式视黄酸的促淋巴管生成作用在淋巴损伤部位增强,并且取决于实验性术后淋巴水肿的治疗持续时间。
DOI:
10.1089/lrb.2021.0073
复制
发表时间:
2022
影响因子:
1.4
通讯作者:
Wong,AlexK
中科院分区:
文献类型:
--
作者:
Lee,GeneK;Perrault,DavidP;Bouz,Antoun;Pourmoussa,AustinJ;Yu,Roy;Kim,SooJung;Gardner,Daniel;Johnson,Maxwell;Park,SunYoung;Park,EunKyung;Seong,YoungJinN;Lee,Sunju;Jung,Eunson;Choi,Dongwon;Hong,Young-Kwon;Wong,AlexK
Background:Patients undergoing surgical treatment for solid tumors are at risk for development of secondary lymphedema due to intraoperative lymphatic vessel injury. The damaged lymphatic vessels fail to adequately regenerate and lymphatic obstruction leads to fluid and protein accumulation in the interstitial space and chronic lymphedema develops as a result. There are currently no effective pharmacological agents that reduce the risk of developing lymphedema or treat pre-existing lymphedema, and management is largely palliative. The present study investigated the efficacy of various 9-cisretinoic acid (9-cisRA) dosing strategies in reducing postsurgical lymphedema by utilizing a well-established mouse tail lymphedema model.Methods and Results:Short-duration treatment with 9-cisRA did not demonstrate a significant reduction in postoperative tail volume, nor an improvement in lymphatic clearance. However, long-term treatment with 9-cisRA resulted in decreased overall tail volume, dermal thickness, and epidermal thickness, with an associated increase in functional lymphatic clearance and lymphatic vessel density, assessed by LYVE-1 immunostaining, compared with control. These effects were seen at the site of lymphatic injury, with no significant changes observed in uninjured sites such as ear skin and the diaphragm.Conclusions:Given the reported results indicating that 9-cisRA is a potent promoter of lymphangiogenesis and improved lymphatic clearance at sites of lymphatic injury, investigation of postoperative 9-cisRA administration to patients at high risk of developing lymphedema may demonstrate positive efficacy and reduced rates of postsurgical lymphedema.
登录
查看更多内容
影响因子:
20.3
作者:
Uckun,FM;Gajl-Peczalska,KJ;Provisor,AJ;Heerema,NA
通讯作者:
Heerema,NA
影响因子:
6.5
作者:
L. Secker;J. Chessells;E. Stewart;G. Swansbury;S. Richards;S. Lawler
通讯作者:
S. Lawler
影响因子:
--
作者:
E. Prigogina;G. Puchkova;S. A. Mayakova
通讯作者:
S. A. Mayakova
DOI:
10.1200/jco.1987.5.7.1015
发表时间:
1987
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Dahl,GV;Rivera,GK;Look,AT;Hustu,HO;Kalwinsky,DK;Abromowitch,M;Mirro,J;Ochs,J;Murphy,SB;Dodge,RK
通讯作者:
Dodge,RK
DOI:
--
发表时间:
1986
期刊:
影响因子:
--
作者:
S. Raimondi;DorothyL. Williams;T. Callihan;S. Peiper;G. Rivera;S. Murphy
通讯作者:
S. Murphy